Neuropace Inc. Common Stock is a medical technology company engaged in the development and commercialization of implantable neurostimulation devices for the treatment of neurological disorders. The company’s innovative products provide targeted therapy, helping patients with epilepsy and refractory partial seizures. With a focus on advancing patient care, Neuropace Inc. aims to improve the quality of life for individuals suffering from these debilitating conditions.
